The Claim
In adults receiving low-intensity or moderate-intensity statin therapy, there is a 10% relative increase in new-onset diabetes diagnoses compared to placebo, with an absolute annual risk increase of 0.12%, primarily due to small elevations in blood glucose and HbA1c levels that push individuals near the diagnostic threshold over the cutoff for diabetes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking low or moderate doses of statin drugs slightly raises the chance of being diagnosed with diabetes because it can push blood sugar levels just high enough to cross the line into the diabetes range.
See the scientific wording
Statin therapy causes a 10% relative increase in new-onset diabetes diagnoses in adults receiving low-intensity or moderate-intensity statin regimens compared to placebo, with an absolute annual risk increase of 0.12%, primarily due to small upward shifts in blood glucose and HbA1c levels that push individuals near the diabetes threshold over the diagnostic cutoff.
What the research says
1 studyThe study found that statins slightly raise blood sugar and lead to a small increase in diabetes diagnoses, mostly in people who were already close to having diabetes. This matches what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.